29.11.2012 Views

Oral and Poster Abstracts

Oral and Poster Abstracts

Oral and Poster Abstracts

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

3 Canadian Food Inspection Agency, Epidemiology <strong>and</strong> Surveillance<br />

Section, Ottawa, Canada<br />

Bovine Spongiform Encephalopathy (BSE) was first diagnosed in<br />

Canada in 1993, in a cow imported from the United Kingdom. In 2003,<br />

the first indigenous case of BSE was diagnosed. To the end of 2007, a<br />

total of 12 indigenous cases of BSE had been diagnosed in cattle born<br />

in Western Canada. From the time Canada made BSE reportable in<br />

1990, surveillance has evolved from passive to active, with a markedly<br />

greater intensity following the discovery of the first indigenous case.<br />

To assess Canada’s true prevalence of BSE <strong>and</strong> the effectiveness of its<br />

surveillance, a retrospective study was designed based on the r<strong>and</strong>om<br />

selection of 3,712 samples from the 95,383 cattle brain samples<br />

submitted for BSE testing between 1992 <strong>and</strong> 2005. The sampling plan<br />

was based on an a priori estimation of the proportional distribution of<br />

National, Western <strong>and</strong> Eastern BSE surveillance samples by Office<br />

International des Epizooties (OIE) surveillance stream (clinical<br />

suspect, casualty slaughter, fallen stock, <strong>and</strong> routine slaughter). For<br />

each sample, data was obtained by record tracing <strong>and</strong> interviewing of<br />

identifiable current <strong>and</strong> original owners. Information recorded<br />

comprised sampling site <strong>and</strong> date, age of the animal, date of birth,<br />

breed, production type, province of sampling, province of birth, clinical<br />

signs preceding <strong>and</strong> reason for death, diagnostic test used <strong>and</strong> test<br />

result. Each sample was classified by OIE surveillance stream.<br />

Analyses on a National, Western <strong>and</strong> Eastern basis highlighted regional<br />

variability among surveillance strategies. Reflecting underlying<br />

population demographics <strong>and</strong> market flows, Eastern Canadian<br />

surveillance emphasized deadstock/renderer sampling (70.5%) while<br />

surveillance in Western Canada focused on on-farm sampling (84.1%).<br />

Sampling in Western Canada was predominantly from beef cattle<br />

(78.3%), with a mean age at sampling of 8.1 years. In Eastern Canada,<br />

the majority of samples originated from dairy cattle (84%), with a mean<br />

age at sampling of 4.7 years. The majority of samples examined were<br />

classified as casualty slaughter (63.7% in Eastern Canada <strong>and</strong> 80.4% in<br />

Western Canada). National, Eastern Canada <strong>and</strong> Western Canada<br />

prevalence estimates were determined. Results of the study have<br />

contributed to a broader assessment of the natural history of BSE in<br />

North America.<br />

86 Pregsure Trivalent Induces Much Higher Neutralising<br />

Antibody Titres against BVDV-2 Strains than Monovalent<br />

BVD Vaccines<br />

R. Raue, D. Hurst, J. Salt<br />

Pfizer Animal Health, R&D, S<strong>and</strong>wich, United Kingdom<br />

Objectives: Bovine viral diarrhoea virus (BVDV) is one of the most<br />

common <strong>and</strong> economically important viruses causing infections in<br />

cattle. Recently, severe outbreaks of BVDV-2 have been described in<br />

the UK. In addition, isolation of BVDV-2 has been reported in most<br />

European countries. As vaccination against BVDV is most often<br />

performed with inactivated vaccines, neutralising antibodies can be a<br />

good in vitro indicator of the ability to protect against a certain BVDV<br />

strain or type. This study was designed to compare the neutralisation<br />

antibody titres induced after vaccination with a novel vaccine PregSure<br />

Trivalent (Pfizer Animal Health), Bovilis BVD (Intervet) <strong>and</strong> Bovidec<br />

(Novartis Animal Health) against a panel of BVDV-1 <strong>and</strong> 2 strains.<br />

Materials <strong>and</strong> Method: Serum samples were collected from calves 3<br />

weeks after vaccination either with PregSure Trivalent, Bovilis BVD or<br />

Bovidec according to the recommendations of the manufacturer. They<br />

were tested in a serum neutralisation test against 11 BVDV-1 strains,<br />

representing genotypes 1a, 1b <strong>and</strong> 1d to 1i, as well as 4 BVDV-2 strains<br />

from Europe <strong>and</strong> the US.<br />

Results: The geometric mean titre in log2 for the 11 BVDV-1 strains<br />

were between 7.3 <strong>and</strong> 10.8 for PregSure Trivalent, 5.7 <strong>and</strong> 9.5 for<br />

Bovilis BVD <strong>and</strong> 4.0 <strong>and</strong> 8.2 for Bovidec. With all vaccine sera<br />

BVDV-1h strain G-AU was neutralised best <strong>and</strong> BVDV-1d strain<br />

PI810 worst. The geometric mean titre in log2 for the 4 BVDV-2<br />

strains where between 8.5 <strong>and</strong> 10.1 for PregSure Trivalent, 1.9 <strong>and</strong> 5.1<br />

for Bovilis BVD <strong>and</strong> 1.2 <strong>and</strong> 2.2 for Bovidec. Therefore, PregSure<br />

Trivalent serum samples showed an equal ability to neutralise BVDV-<br />

1 <strong>and</strong> 2 strains whereas Bovilis BVD <strong>and</strong> Bovidec serum samples<br />

showed a reduction in the ability to neutralise BVDV-2 strains by at<br />

least 4 log2. In some cases Bovilis BVD <strong>and</strong> Bovidec vaccine sera were<br />

not able to neutralise BVDV-2 strains at all.<br />

Conclusions: The results of this study demonstrate that the level of<br />

neutralising antibodies after vaccination with PregSure Trivalent is<br />

remarkably higher against BVDV-2 strains than those of monovalent<br />

inactivated BVD vaccines. In combination with the demonstration of<br />

12 month protection against BVDV-1 <strong>and</strong> 2 by challenge, this data<br />

indicate that the novel vaccine PregSure Trivalent gives a<br />

comprehensive cover against all types of BVDV field infections.<br />

Key words: PregSure Trivalent, BVDV-1, BVDV-2, neutralisation<br />

87 Monitoring of a BVDV Infection in a Vaccinated Herd by<br />

Testing of Milk for Antibodies against NS3<br />

B. Makoschey 1 , H. Kuijk 2 , J. Mars 3 , W. bij de Weg 2 , P. Franken 3<br />

1<br />

Intervet-Schering Plough, Int. Marketing, Boxmeer, Netherl<strong>and</strong>s<br />

2<br />

Intervet-Schering Plough, Intervet Netherl<strong>and</strong>s, Boxmeer,<br />

Netherl<strong>and</strong>s<br />

3<br />

Animal Health Service Deventer, Deventer, Netherl<strong>and</strong>s<br />

Objectives: It has been demonstrated earlier, that an inactivated<br />

vaccine against the bovine viral diarrhoea virus (BVDV) in<br />

combination with a suitable test for antibodies against non structural<br />

proteins (NS) exhibits properties of a marker vaccine: animals usually<br />

remain seronegative after vaccination but develop NS specific<br />

antibodies after field virus infection. In this study, it should be<br />

established, whether the NS3 antibody testing of individual or bulk<br />

milk samples is likewise suitable for differentiation between BVDV<br />

vaccinated <strong>and</strong> field virus infected animals.<br />

Materials <strong>and</strong> Methods: The study was performed on a Dutch dairy<br />

farm. After being certified as BVDV-virus-free in 2002, the farm<br />

experienced a new outbreak of BVDV in 2005. A herd vaccination<br />

program was initiated using an inactivated BVDV vaccine (Bovilis R<br />

BVD, Intervet International). Seventeen cows were selected for further<br />

follow up: blood samples, individual milk samples <strong>and</strong> bulk milk<br />

samples were collected at pre-set time points. BVDV neutralizing<br />

antibody titers were measured <strong>and</strong> the NS3 antibody response was<br />

measured in a commercial ELISA test (Cedi-testR BVDV, Cedi<br />

Diagnostics, Lelystad, The Netherl<strong>and</strong>s).<br />

Results: All animals that were seronegative before vaccination<br />

developed BVDV neutralizing antibodies after immunization. Three of<br />

the ten vaccinated animals showed an increase in the titers of BVDV<br />

neutralising antibodies, between study days 56 <strong>and</strong> 210, indicating that<br />

they experienced a field virus infection. All samples from animals that<br />

were vaccinated but not infected were tested negative for NS3 specific<br />

antibodies at all time points. The samples from the three animals that<br />

were infected after the vaccination were tested negative for NS3<br />

specific antibodies at Day 0, 28 <strong>and</strong> 56, but were positive thereafter. In<br />

contrast, all serum samples taken from animals that have been infected<br />

with BVDV field virus were tested positive for NS3 specific antibodies.<br />

The overall majority (37/44) of the milk samples for these animals were<br />

also tested positive in the NS3 ELISA. Likewise, the bulk milk samples<br />

were positive in the NS3 ELISA, with the exception of the sample<br />

taken at study day 28.<br />

Conclusions: The results obtained demonstrate that a field virus<br />

infection with BVDV can be monitored by measurement of NS<br />

antibodies in blood or (bulk) milk samples, even in a vaccinated herd.<br />

88 Transmission of Bovine Viral Diarrhoea Virus (BVDV) from<br />

Persistently Infected Calves to Naive in-contact Cattle is Very<br />

Rapid <strong>and</strong> Efficient<br />

B. Makoschey 1 , M. Janssen 2<br />

1 Intervet-Schering-Plough, Int. Marketing, Boxmeer, Netherl<strong>and</strong>s<br />

2 Intervet-Schering Plough, R&D, Boxmeer, Netherl<strong>and</strong>s<br />

Objectives: The transmission of bovine viral diarrhoea virus (BVDV)<br />

from persistently infected (PI) calves to in-contact animals is generally<br />

considered to happen very efficiently. It should be determined, whether<br />

naive animals housed in adjacent pens to a PI are readily infected or<br />

whether housing in the same pen is required for efficient infection.<br />

Materials <strong>and</strong> Methods: Four heifers at the age of 10 months or older,<br />

negative for antibodies against BVDV, <strong>and</strong> free of BVDV <strong>and</strong> one three<br />

months old PI calf were included in the study. The heifers were housed as<br />

one group in a pen. The PI calf was housed in an adjacent pen. The animals<br />

were allowed to have direct contact through the fence. Blood samples were<br />

taken weekly <strong>and</strong> BVDV neutralising antibodies were determined.<br />

Results: All four heifers seroconverted within four weeks after<br />

introduction of the PI calf. These results, indicate that the infection with<br />

BVDV had occurred during the first week after the first contacts with<br />

the PI animal.<br />

Infectious <strong>and</strong> Zoonotic Deseases (Public Health) 77

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!